Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus.

May, Verena; Berchtold, Susanne; Berger, Alexander; Venturelli, Sascha; Burkard, Markus; Leischner, Christian; Malek, Nisar P; Lauer, Ulrich M.

Afiliação

May V; Department of Internal Medicine I (Gastroenterology, Gastroenterologic Oncology, Hepatology, Infectiology and Geriatric Medicine), University Hospital Tuebingen, D-72076 Tuebingen, Germany.
Berchtold S; Department of Internal Medicine VIII (Medical Oncology and Pneumology), University Hospital Tuebingen, D-72076 Tuebingen, Germany.
Berger A; German Cancer Consortium (DKTK), DKFZ Partner Site Tuebingen, Interfaculty Institute of Biology, D-72076 Tuebingen, Germany.
Venturelli S; Boehringer Ingelheim Pharma GmbH and Co. KG, D-88397 Biberach/Riss, Germany.
Burkard M; Department of Vegetative and Clinical Physiology, University Hospital Tuebingen, D-72076 Tuebingen, Germany.
Leischner C; Department of Vegetative and Clinical Physiology, University Hospital Tuebingen, D-72076 Tuebingen, Germany.
Malek NP; Department of Vegetative and Clinical Physiology, University Hospital Tuebingen, D-72076 Tuebingen, Germany.
Lauer UM; Department of Internal Medicine I (Gastroenterology, Gastroenterologic Oncology, Hepatology, Infectiology and Geriatric Medicine), University Hospital Tuebingen, D-72076 Tuebingen, Germany.

Oncol Lett ; 18(5): 5534-5542, 2019 Nov.

Article em En | MEDLINE | ID: mdl-31612061